Rite Aid (NYSE:RAD) reports same-store sales declined 2.5% in Q2.
Comparable front-end sales +0.1% and pharmacy comp down 3.6%.
Retail pharmacy sales slipped 2.5% to $6.49B due to decrease in same store sales.
RELACIONADA: Finanzas: Rite Aid Reports Fiscal 2017 Second Quarter Results
Prescription sales accounted for 68.5% of total drugstore sales.
Gross margin rate squeezed 120 bps to 23.9%.
SG&A expense rate improved 40 bps to 22.1%.
Adjusted EBITDA fell 9.8% to $312.7M.
Store count: Wellness centers +355 Y/Y to 2,214; Total stores -11 Y/Y to 4,550.
RAD +0.49% premarket.
Fuente: Seeking Alpha
